ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Xi praises WHO and says vaccine will be a 'global public good'

Chinese president backs comprehensive review of coronavirus response

Chinese President Xi Jinping speaks at the World Health Assembly via video link on Monday. (Nikkei screenshot) 

SHANGHAI/TOKYO -- Chinese President Xi Jinping painted his country as a global leader at the World Health Organization's annual meeting Monday, calling for international cooperation against the new coronavirus, pledging $2 billion toward this end, and promising to make any Chinese vaccine "a global public good" when available.

Xi also deflected criticism of China's initial response, saying all countries are vulnerable.

"The virus does not respect borders," he said in a roughly 10-minute speech via video at the World Health Assembly. "Nor is race or nationality relevant in the face of the disease."

"We have provided information to WHO and relevant countries in a most timely fashion," Xi said. "We have released the genome sequence at the earliest possible time. We have shared control and treatment experience with the world without reservation. We have done everything in our power to support and assist countries in need."

The Chinese leader countered American criticism of the WHO, saying that "its good work is applauded by the international community." He said the WHO should lead the global response to COVID-19 and called on the international community to "increase political and financial support" for the agency.

Prior to the meeting, the European Union submitted a draft resolution backed by more than 100 countries for an independent investigation to "identify the zoonotic source of the virus and the route of introduction to the human population, including the possible role of intermediate hosts."

Under pressure to submit China to a probe, Xi said he supported "the idea of a comprehensive review of the global response to COVID-19 after it is brought under control" -- not the causes of the outbreak.

Xi said a review "to sum up experience and address deficiencies" should be based on science and professionalism, led by the WHO and conducted in an objective and impartial manner.

Calling for greater global governance in public health, Xi offered $2 billion over the next two years to fight the pandemic. He proposed to set up a global humanitarian response center in China to fight epidemics by ensuring easier logistics for the delivery of aid.

The Chinese president also called for greater support for Africa to help developing countries there to build capacity and fend off the epidemic.

He said that China, which has poured billions of dollars of investment into the continent in recent years, is helping to build a centers of disease control there using a cooperation mechanism with 30 African hospitals. He did not identify the location of the CDC.

This is on top of a "tremendous amount" of medical supplies sent to over 50 African countries in recent months," he said.

Taiwanese President Tsai Ing-wen, wearing a mask, observes soldiers demonstrate drills at a military base camp in Tainan, Taiwan, on April 9.   © Reuters

Earlier Monday, Taiwan dropped its bid for observer status at the WHA meeting, saying the institution yielded to pressure from China in not inviting the island to attend.

Foreign Minister Joseph Wu told reporters that countries want to use the meeting to concentrate on containing the pandemic, and suggested that the proposal for Taiwan to join be taken up later this year. The WHA agreed to this at the online meeting.

"After careful deliberation, we have accepted the suggestion from our allies and like-minded nations to wait until the resumed session before further promoting our bid," Wu said.

"The Ministry of Foreign Affairs expresses deep regret and strong dissatisfaction that the World Health Organization Secretariat has yielded to pressure from the Chinese government and continues to disregard the right to health of the 23 million people of Taiwan," he added. "The people of Taiwan abhor the two-faced behavior of the Chinese government, which claims to care for their health and welfare while actually seeking to deprive them of their right to health at every turn."

Twenty-two nations -- 14 of the 15 countries that recognize the Taipei government and a group of eight led by the U.S. and Japan -- had been forecast to back Taiwan's participation in a vote ahead of the meeting.

While many countries with official relations with Beijing are upset at China's initial handling of the coronavirus, the pulling of the vote shows that they are not willing to risk political and economic ties to support Taipei's drive for WHA representation.

Taiwan has failed to win observer status since President Tsai Ing-wen, a China-skeptic, first came to power in 2016. But the island's campaign this year has extra heft because of its adroit response to the coronavirus, recording only 440 infections and seven deaths so far.

A formal proposal was submitted to the WHO by Belize and Central American, Caribbean, and Pacific states that have maintained ties with Taipei, despite the Solomon Islands and Kiribati switching sides to Beijing last year.

New Zealand in particular has angered Beijing for both backing Taiwan's participation in the meeting, and joining over 60 countries in calls for an international investigation on the origins of COVID-19. A Chinese foreign ministry spokesperson last week called for New Zealand to "stop making wrong statements on Taiwan to avoid damaging our bilateral relationship."

WHO officials have come under fire for alleged acquiescence to China. Most notably, U.S. President Donald Trump has claimed the organization ignored Taiwan's warnings of atypical pneumonia cases in mainland China.

"WHO had determined that the information provided by Taiwan held no value, and it neglected to respond," Taiwanese health minister Chen Shih-chung said last week.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more